Long-term monitoring and treatment of venous thromboembolic disease: recommendations of the Thromboembolic Disease Group of the Spanish Society of Internal Medicine 2024.

M Martín Del Pozo, M Martín Asenjo, A I Franco Moreno, E Usandizaga de Antonio, F Galeano Valle
{"title":"Long-term monitoring and treatment of venous thromboembolic disease: recommendations of the Thromboembolic Disease Group of the Spanish Society of Internal Medicine 2024.","authors":"M Martín Del Pozo, M Martín Asenjo, A I Franco Moreno, E Usandizaga de Antonio, F Galeano Valle","doi":"10.1016/j.rceng.2024.10.004","DOIUrl":null,"url":null,"abstract":"<p><p>Venous thromboembolim (VTE) is a highly prevalent condition that requires long-term monitoring and treatment. This monitoring includes: 1) completing the etiological study and determining the risk of VTE recurrence; 2) establishing the optimal duration of anticoagulant treatment, as well as the type of therapy and its dosage; 3) estimating the risk of bleeding, and 4) identifying the occurrence of chronic complications. This consensus document, prepared by the VTE Group of the Spanish Society of Internal Medicine (SEMI), aims to update and establish consensus recommendations on these aspects. The document focuses on four aspects of management: the first includes risk factors for VTE recurrence after an unprovoked VTE episode and describes the predictive scores of VTE recurrence; the second focuses on risk factors for bleeding; the third provides recommendations for long-term follow-up in VTE, addressing specific considerations for screening chronic thromboembolic pulmonary hypertension and post-thrombotic syndrome of the lower limbs; and the fourth provides guidance on the optimal duration of extended anticoagulant treatment, as well as the type of therapy and its dosage. For each area, an exhaustive literature review was conducted, analyzing the updated VTE clinical guidelines and recent studies. This document is intended to be a guide in the long-term management of VTE based on the most current knowledge.</p>","PeriodicalId":94354,"journal":{"name":"Revista clinica espanola","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista clinica espanola","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.rceng.2024.10.004","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Venous thromboembolim (VTE) is a highly prevalent condition that requires long-term monitoring and treatment. This monitoring includes: 1) completing the etiological study and determining the risk of VTE recurrence; 2) establishing the optimal duration of anticoagulant treatment, as well as the type of therapy and its dosage; 3) estimating the risk of bleeding, and 4) identifying the occurrence of chronic complications. This consensus document, prepared by the VTE Group of the Spanish Society of Internal Medicine (SEMI), aims to update and establish consensus recommendations on these aspects. The document focuses on four aspects of management: the first includes risk factors for VTE recurrence after an unprovoked VTE episode and describes the predictive scores of VTE recurrence; the second focuses on risk factors for bleeding; the third provides recommendations for long-term follow-up in VTE, addressing specific considerations for screening chronic thromboembolic pulmonary hypertension and post-thrombotic syndrome of the lower limbs; and the fourth provides guidance on the optimal duration of extended anticoagulant treatment, as well as the type of therapy and its dosage. For each area, an exhaustive literature review was conducted, analyzing the updated VTE clinical guidelines and recent studies. This document is intended to be a guide in the long-term management of VTE based on the most current knowledge.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
静脉血栓栓塞性疾病的长期监测和治疗:西班牙内科医学会血栓栓塞性疾病小组 2024 年的建议。
静脉血栓栓塞(VTE)是一种需要长期监测和治疗的高发疾病。这种监测包括1)完成病因学研究并确定 VTE 复发风险;2)确定抗凝治疗的最佳持续时间以及治疗类型和剂量;3)估计出血风险;4)确定慢性并发症的发生。本共识文件由西班牙内科医学会(SEMI)VTE 小组编写,旨在更新和确立有关这些方面的共识建议。文件重点关注四个方面的管理:第一方面包括无诱因 VTE 复发的风险因素,并描述了 VTE 复发的预测评分;第二方面关注出血的风险因素;第三方面提供了 VTE 长期随访的建议,涉及筛查慢性血栓栓塞性肺动脉高压和下肢血栓后综合征的具体注意事项;第四方面就延长抗凝治疗的最佳持续时间以及治疗类型和剂量提供了指导。针对每个领域,我们都进行了详尽的文献综述,分析了最新的 VTE 临床指南和近期研究。本文件旨在以最新知识为基础,为 VTE 的长期管理提供指导。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Which one is a better predictor of prognosis in COVID-19: analytical biomarkers or PaO2/FiO2? The rights and interests of participants as limits to clinical trials. Artificial intelligence in clinical practice: Quality and evidence. Incidence of pregnancy related pulmonary embolism in Spain 2016-2021: an observational population-based retrospective study Soluble receptor for advanced glycation end-products positively correlated to kidney injury with coronary heart disease
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1